NIH Guide to Grants and Contracts

The NIH Guide for Grants and Contracts is our official publication for NIH grant policies, guidelines and funding opportunities. We publish daily, and issue a table of contents weekly. Learn more about the NIH Guide and subscribe today!

The old advanced search is still avaliable.

New Features:

  • Tabular view - You can now view the search results in table format.
  • Export to excel - Search results can now be exported to excel for reporting purposes.

Results: 1 to 25 of 1411

Display Results as:

Title FOA Number Organization Released Expires Activity Code
Pre-application for a Biomedical Technology Research Resource (X02)  PAR-17-315  NIGMS  06-14-2017  03-16-2020  X02 
NeuroNEXT Infrastructure Resource Access (X01)  PAR-15-195  NINDS  04-30-2015  01-24-2018  X01 
Discovery of Genetic Basis of Monogenic Heart, Lung, Blood, and Sleep Disorders (X01)  PAR-15-314  NHLBI  07-29-2015  06-16-2018  X01 
NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01)  PAR-16-021  NHLBI  10-30-2015  10-19-2018  X01 
Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01)   PAR-17-269  NHGRI  05-03-2017  07-11-2020  X01 
NIDDK Central Repositories Non-renewable Sample Access (X01)  PAR-17-270  NIDDK  05-03-2017  07-01-2020  X01 
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention Infrastructure Resource Access (X01)  PAR-17-277  NINDS  05-10-2017  01-24-2018  X01 
Population Assessment of Tobacco and Health (PATH) Biospecimen Access (X01)  PAR-17-458  NIDA  08-15-2017  11-01-2020  X01 
Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01, Clinical Trials Not Allowed)  PAR-18-583  Roadmap  01-16-2018  03-23-2018  X01 
Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (UT2 -Clinical Trial Optional)  PAR-18-580  NIAAA  01-12-2018  12-05-2020  UT2 
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed  PAR-18-310  NCI  10-12-2017  10-09-2020  UH3 
BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 - Clinical Trial Required)  RFA-NS-18-023  NINDS  12-21-2017  10-22-2020  UH3 
Fast-Track Development of Medications to Treat Cannabis Use Disorders (UG3/UH3)  PAR-15-267  NIDA  05-26-2015  05-08-2018  UH2/UH3 
Fast-Track Development of Medications to Treat Cannabis Use Disorders (UG3/UH3 Clinical Trial Optional)  PAR-18-221  NIDA  11-29-2017  05-08-2018  UH2/UH3 
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed)  PAR-18-317  NCI  10-12-2017  10-09-2020  UH2/UH3 
Informatics Methodology and Secondary Analyses to Explore Shared Immunology Study Data in ImmPort (UH2)  PAR-16-253  NIAID  05-10-2016  10-05-2018  UH2 
Bench Testing Therapeutic/Indication Pairing Strategies (UG3/UH3)  PAR-17-465  NCATS  08-21-2017  09-08-2020  UH2 
Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3)   PAR-16-065  NIMH  12-21-2015  01-25-2018  UG3/UH3 
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3)  PAR-16-300  NHLBI  05-31-2016  01-25-2018  UG3/UH3 
New Informatics Tools and Methods to Enhance US Cancer Surveillance and Research (UG3/UH3)   PAR-16-349  NCI  06-29-2016  04-17-2019  UG3/UH3 
Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3)  PAR-17-128  NCI  01-19-2017  01-10-2020  UG3/UH3 
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3)  PAR-17-175  NCCIH  (formerly NCCAM) 03-10-2017  03-01-2020  UG3/UH3 
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3)  PAR-17-174  NCCIH  (formerly NCCAM) 03-10-2017  11-05-2019  UG3/UH3 
Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3 Clinical Trial Optional)  PAR-18-248  NCI  11-29-2017  01-10-2020  UG3/UH3 
Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional)   PAR-18-268  NIMH  11-21-2017  10-25-2018  UG3/UH3 

Current Search

Refine Your Results

Program Announcements (PAs)

Parent Announcments Only

Requests for Applications (RFAs)

Issuing Only

All Organizations

AHRQ

CDC

DHHS

DOJ

EPA

FDA

FIC

HRSA

NASA

NCATS

NCBDDD

NCCDPHP

NCCIH

NCEH

NCHSTP

NCI

NCID

NCIPC

NCMHD

NCPHI

NCRR

NEI

NHGRI

NHLBI

NIA

NIAAA

NIAID

NIAMS

NIBIB

NICHD

NIDA

NIDCD

NIDCR

NIDDK

NIEHS

NIGMS

NIH

NIMH

NIMHD

NINDS

NINR

NIOSH

NIP

NLM

OAR

OBSSR

OD

ODP

ODS

OPHR

ORD

ORI

ORIP

ORWH

OSC

Roadmap

SAMHSA

*On or After
*On or After
(e.g. "K" for K01 or K02, K05, etc.)
Back to Top